Key points in this year's conference: The 30th Carl M Pearson Symposium, held in Marina Del Rey Marriott on April 27th - 29th attracted over 150 attendees across the Southern California community including rheumatologists, interested physicians health care professionals and rheumatology fellows. The conference focused on most the current information and insights on treatment of rheumatic diseases including Myositis, Rheumatoid Arthritis, Lupus, Pain Management and Scleroderma.
Dr. Moreland emphasized the need to follow pts quantitatively, while, at least from his point of view, pointing out that acute phase reactants may not be the only or best way to follow RA pts. He seemed to favor the CDAI or some measure not requiring laboratory data.
He also reviewed the newer molecules including tyrosine kinase inhibitors and anti-IL-17 for the future treatment of RA.
Dr. Crofford concentrated on pain, its understanding and treatment. She pointed out the important contribution of central pathways to pain and the importance of treating that aspect of pain, rather than only peripheral or anatomic causes of pain. She made an excellent case for using narcotics cautiously when treating fibromyalgia, while also emphasizing that there are other medications and treatments that are often effective.
Dr. Dore gave an excellent presentation about the expectations and challenges when converting one's practice to an electronic format. There are advantages, clear problems and multiple approaches. In the end, like it or not, she said, some form of electronic health/medical record will need to be used and the earlier the switch is made, the better.
Dr. Hahn, ever the superb lecturer, discussed the real issues and potential approaches to pregnancy in SLE patients as well as filling the audience in on drugs which may become available in SLE in the future.
Dr. Motamedi (check spelling) gave an excellent review of the usefulness and differential diagnosis of imaging modalities in selected rheumatic syndromes. His imaging quiz was, as usual, a real time for clinical pearls and good fun (with prizes!).
The "thieves’ market" of clinical cases was well attended, despite it being Sunday morning and a "new" disease, IgG4 -related disease, was highlighted.
Overall, the 151 participants in this year's 3oth Frontiers in Rheumatology seemed to have truly enjoyed the learning and camaraderie associated with this Southern California institution.